Invesco Dynamic Biotechnology & Genome ETF Stock Forecast, Price & News

Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Frequently Asked Questions

How has Invesco Dynamic Biotechnology & Genome ETF's stock price been impacted by Coronavirus?

Invesco Dynamic Biotechnology & Genome ETF's stock was trading at $45.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PBE shares have increased by 56.5% and is now trading at $71.82.
View which stocks have been most impacted by COVID-19.

Who are Invesco Dynamic Biotechnology & Genome ETF's key executives?

Invesco Dynamic Biotechnology & Genome ETF's management team includes the following people:

• H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive Officer
• Bruce T. Duncan, Chief Financial Officer, Treasurer
• Kevin R. Gustafson, Chief Compliance Officer
• Keith A Ovitt, Secretary
• Ronn R. Bagge, Trustee
• Marc M Kole, Trustee
• D. Mark McMillan, Trustee
• Philip M. Nussbaum Mba, Trustee
• Donald H. Wilson, Trustee

What other stocks do shareholders of Invesco Dynamic Biotechnology & Genome ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Biotechnology & Genome ETF investors own include Pfizer (PFE), Intel (INTC), Align Technology (ALGN), Micron Technology (MU), Activision Blizzard (ATVI), DocuSign (DOCU), Inovio Pharmaceuticals (INO), Mastercard (MA), Momo (MOMO) and ONEOK (OKE).

What is Invesco Dynamic Biotechnology & Genome ETF's stock symbol?

Invesco Dynamic Biotechnology & Genome ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PBE."

Who are Invesco Dynamic Biotechnology & Genome ETF's major shareholders?

Invesco Dynamic Biotechnology & Genome ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Morgan Stanley (3.88%), Royal Bank of Canada (1.45%), LPL Financial LLC (1.04%), Anfield Capital Management LLC (0.68%), YHB Investment Advisors Inc. (0.54%) and Goldman Sachs Group Inc. (0.34%).

Which institutional investors are selling Invesco Dynamic Biotechnology & Genome ETF stock?

PBE stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Citigroup Inc., Morgan Stanley, Raymond James & Associates, Citadel Advisors LLC, Neuberger Berman Group LLC, Commonwealth Equity Services LLC, and Stratos Wealth Partners LTD..

Which institutional investors are buying Invesco Dynamic Biotechnology & Genome ETF stock?

PBE stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Pacific Sun Financial Corp, LPL Financial LLC, Banque Cantonale Vaudoise, Selective Wealth Management Inc., Koshinski Asset Management Inc., Ibex Wealth Advisors, and Raymond James Financial Services Advisors Inc..

How do I buy shares of Invesco Dynamic Biotechnology & Genome ETF?

Shares of PBE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invesco Dynamic Biotechnology & Genome ETF's stock price today?

One share of PBE stock can currently be purchased for approximately $71.82.

How much money does Invesco Dynamic Biotechnology & Genome ETF make?

Invesco Dynamic Biotechnology & Genome ETF has a market capitalization of $280.82 million.

What is Invesco Dynamic Biotechnology & Genome ETF's official website?

The official website for Invesco Dynamic Biotechnology & Genome ETF is www.invescopowershares.com.

Where are Invesco Dynamic Biotechnology & Genome ETF's headquarters?

Invesco Dynamic Biotechnology & Genome ETF is headquartered at 301 West Roosevelt Road, WHEATON, IL 60187, United States.

How can I contact Invesco Dynamic Biotechnology & Genome ETF?

Invesco Dynamic Biotechnology & Genome ETF's mailing address is 301 West Roosevelt Road, WHEATON, IL 60187, United States. The company can be reached via phone at +1-800-9830903.